Endovascular repair of thoracoabdominal aneurysms

Article

关键词: THORACIC AORTIC-ANEURYSMS;    SURGICAL REPAIR;    HYBRID APPROACH;    RENAL-FAILURE;    RISK;    GRAFTS;    TRIAL;    EXPERIENCE;    EXCLUSION;    SURGERY;   

DOI  :  10.1161/CIRCULATIONAHA.107.716134

来源: SCIE

【 摘 要 】

Background - Morbidity and mortality after conventional repair of thoracoabdominal aneurysms remain high. Alternative techniques have been proposed and are the subject of this report. Methods and Results - Endovascular grafts that have a means of incorporating the visceral vessels into the aortic repair were divided into devices with fenestrations and those with formal branches. Hybrid procedures whereby an extra-anatomic bypass procedure is used to provide inflow to the renal and mesenteric arteries followed by aortic relining with stent grafts were reviewed and tabulated. A description of the techniques and review of the current results are provided. Only 4 series with > 10 cases of hybrid procedures have been published. The experience with such a procedure suggests feasibility, but most reports describe a persistently high risk of mortality (up to 25%). Larger series of fenestrated stent grafts to treat juxtarenal aneurysms have been published, and intermediate-term results confirm the safety and efficacy of the procedure. A larger multicenter trial is under way. Other pure endovascular methods have been used to treat thoracoabdominal aneurysms with both reinforced fenestrations and directional branches. Without counting small series (< 10 cases), 2 series exist with approximate to 100 cases that noted perioperative mortality rates between 3% and 6%, without evidence of late ruptures. Conclusions - Endovascular repair of thoracoabdominal aneurysms is feasible and is associated with relatively low perioperative mortality. Several methods of visceral vessel incorporation have been described. Because of persistently high mortality, hybrid procedures will likely be relegated to nonsurgical and nonendovascular patients with sizable aneurysms. Endografts with branches continue to evolve and will be assessed in the context of clinical trials.

【 授权许可】

Free